RFG Advisory LLC Raises Stock Holdings in The Chemours Company $CC

Key Points

• RFG Advisory LLC increased its holdings in The Chemours Company by 52.7% during the second quarter, totaling approximately $1.25 million in value.
• In a recent insider transaction, CEO Denise Dignam purchased 4,068 shares valued at about $49,060, increasing her stake in the company.
• Chemours reported an earnings per share (EPS) of $0.58 for the last quarter, exceeding the expected $0.46, and experienced a 5% increase in revenue year-over-year.

RFG Advisory LLC lifted its holdings in The Chemours Company (NYSE:CC - Free Report) by 52.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 109,231 shares of the specialty chemicals company's stock after buying an additional 37,678 shares during the quarter. RFG Advisory LLC owned approximately 0.07% of Chemours worth $1,251,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Farther Finance Advisors LLC raised its holdings in shares of Chemours by 170.7% in the first quarter. Farther Finance Advisors LLC now owns 2,290 shares of the specialty chemicals company's stock worth $30,000 after buying an additional 1,444 shares during the period. SouthState Corp bought a new position in Chemours in the first quarter worth approximately $34,000. GAMMA Investing LLC grew its stake in Chemours by 130.7% in the second quarter. GAMMA Investing LLC now owns 3,175 shares of the specialty chemicals company's stock worth $36,000 after purchasing an additional 1,799 shares in the last quarter. CWM LLC grew its stake in Chemours by 34.7% in the second quarter. CWM LLC now owns 4,290 shares of the specialty chemicals company's stock worth $49,000 after purchasing an additional 1,104 shares in the last quarter. Finally, Parallel Advisors LLC grew its stake in Chemours by 132.6% in the second quarter. Parallel Advisors LLC now owns 5,634 shares of the specialty chemicals company's stock worth $65,000 after purchasing an additional 3,212 shares in the last quarter. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Chemours

In other Chemours news, CEO Denise Dignam acquired 4,068 shares of the firm's stock in a transaction dated Friday, August 8th. The stock was purchased at an average price of $12.06 per share, for a total transaction of $49,060.08. Following the acquisition, the chief executive officer owned 191,546 shares in the company, valued at approximately $2,310,044.76. This trade represents a 2.17% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.47% of the company's stock.

Chemours Stock Down 4.4%

Shares of NYSE CC opened at $13.79 on Friday. The company has a current ratio of 1.68, a quick ratio of 0.83 and a debt-to-equity ratio of 17.16. The stock has a market capitalization of $2.06 billion, a PE ratio of -4.93 and a beta of 1.65. The stock's fifty day simple moving average is $15.29 and its two-hundred day simple moving average is $13.00. The Chemours Company has a 12-month low of $9.13 and a 12-month high of $22.38.

Chemours (NYSE:CC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The specialty chemicals company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.12. The business had revenue of $1.62 billion for the quarter, compared to analysts' expectations of $1.57 billion. Chemours had a positive return on equity of 35.14% and a negative net margin of 7.19%.The business's revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.38 EPS. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, analysts expect that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 12th. Stockholders of record on Friday, August 15th were issued a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Friday, August 15th. Chemours's dividend payout ratio is currently -12.50%.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. UBS Group increased their price objective on Chemours from $17.00 to $21.00 and gave the stock a "buy" rating in a research note on Monday, October 6th. Zacks Research raised Chemours from a "strong sell" rating to a "hold" rating in a research note on Wednesday, August 27th. Mizuho dropped their price objective on Chemours from $19.00 to $18.00 and set an "outperform" rating on the stock in a research note on Thursday. Truist Financial increased their price objective on Chemours from $18.00 to $21.00 and gave the stock a "buy" rating in a research note on Tuesday, September 16th. Finally, Royal Bank Of Canada set a $19.00 price objective on Chemours and gave the stock an "outperform" rating in a research note on Tuesday. Five analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Chemours has an average rating of "Hold" and an average target price of $18.50.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.